---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-044657"
form_type: "8-K"
ticker: "APUS"
cik: "0001894525"
company_name: "Apimeds Pharmaceuticals US, Inc."
filed_at: "2026-04-16T23:59:59+00:00"
generated_at: "2026-05-15T05:52:11.097541+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Apimeds expects NYSE notice for late 10-K filing; targets April 30

## Summary
- Filed Form 12b-25 on March 31, 2026 for FY 2025 10-K; will not file within 15-day extension.
- Expects NYSE American non-compliance notice due to failure to timely file 10-K.
- Plans to file 10-K by April 30, 2026; no assurance given.
- Delay driven by ongoing preparation of financial statements and audit completion.

## SEC filing metadata
- accession: 0001213900-26-044657
- form_type: 8-K
- ticker: APUS
- cik: 0001894525
- company_name: Apimeds Pharmaceuticals US, Inc.
- filed_at: 2026-04-16T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1894525/000121390026044657/0001213900-26-044657-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1894525/000121390026044657/ea0286661-8k_apimeds.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-044657
- JSON: https://secwatch.observer/filing/0001213900-26-044657.json
- Plain text: https://secwatch.observer/filing/0001213900-26-044657.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.